Celldex Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
CLDX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
53 Frontage Road, Suite 220, Hampton, NJ

Insiders trading volume in the past year

Celldex Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anthony S. Marucci PRESIDENT & CEO, Director $1.08M +$308K +40% Jun 5, 2025
Samuel Bates Martin Svp And Cfo $996K Jun 5, 2025
Freddy A. Jimenez Svp & General Counsel $889K -$19.1K -2.1% Aug 13, 2025
Richard M. Wright Sr. Vp & Cco $708K Jun 13, 2024
Diane C. Young Svp, Chief Medical Officer $600K Jun 5, 2025
Elizabeth Crowley Sr. Vp & Cpdo $316K Jun 5, 2025
James J. Marino Director $59.1K Jun 5, 2025
Harry Penner Jr Director Jun 5, 2025
Herbert J. Conrad Director Jun 5, 2025
Karen L. Shoos Director Jun 13, 2024
Tibor Keler Executive Vp & Cso Jun 5, 2025
Keith L. Brownlie Director Jun 5, 2025
Denice Torres Director Jun 5, 2025
Sarah Cavanaugh Svp Of Corp Affairs & Admin. Jun 5, 2025
Margo Heath-Chiozzi Svp Of Regulatory Affairs Jun 5, 2025
Rita Jain Director Jun 5, 2025
Cheryl Cohen Director Jun 5, 2025
Ronald Pepin Sr. Vp & Cbo Jun 5, 2025
Garry A. Neil Director Jun 5, 2025

Recent Insider Transactions by Companies or Individuals for Celldex Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.